The FDA grants traditional approval to Keytruda and Keytruda Qlex for TMB-H solid tumors, updating the threshold to at least 13 mutations per megabase.
|Articles|June 19, 2018
CURE Media Group Honored in 20th Anniversary Digital Health Awards Spring 2018 Session
Advertisement
CRANBURY, N.J.--(BUSINESS WIRE)--CURE® Media Group, the nation’s leading digital and print media enterprise dedicated to patients and survivors of cancer, was honored with four Digital Health Awards®, a competition that recognizes the world’s best digital health resources.
Winning contributions for the Spring 2018 session included:
Merit award for “A Whisper and Then a Scream” by Shannon Pulaski (CURE® Magazine);
Bronze award for “Breast Cancer Survivor Sees Red Over Pink” by Barbara Tako (CURE® Magazine);
Merit award for “Redefining Cancer” by Rick Boulay, M.D. (CURE® Magazine); and
Merit award for “Zero Tolerance: Stopping Nurse Bullying Begins with Leadership” by Sarah Handzel, BSN, RN (Oncology Nursing News®)
“We are honored to receive four Digital Health Awards® from the Health Information Resource Center, said, Michael J. Hennessy Jr, president of MJH Associates, parent company of CURE® Media Group. “These awards show the dedication and passion our editorial teams put forth each day.”
The competition — held each spring and fall — featured 80 categories. CURE® Magazine and Oncology Nursing News® were selected from more than 400 entries.
The Health Information Resource CenterSM (HIRC), organizer of the Digital Health Awards, is a national information clearinghouse for professionals who work in consumer health fields.
About CURE Media GroupCURE Media Group is the leading resource for cancer updates, research and education. It combines a full suite of media products, including its industry-leading website, curetoday.com; innovative video programs, such as CURE Connections®; a series of widely attended live events; and CURE® magazine, which reaches over 1 million readers. CURE Media Group is part of the Cranbury, New Jersey—based MJH Associates Inc. family of businesses, which includes the acclaimed OncLive® (onclive.com) platform of resources for the practicing oncologist. For more information, visit curetoday.com or mjhassoc.com.ContactsCURE Media Group Press:Theresa Burek, 609-325-4811tburek@mjhassoc.com
Advertisement
Related to this article
Martha Carlson reflects on her 11 years with metastatic breast cancer and explores how resilience, purpose and the stories we tell ourselves shape the cancer experience.
A study found that 1 in 9 older cancer survivors developed a second cancer, highlighting why routine screening remains important beyond five years.
After breast cancer at 30, Aisha shares her journey through motherhood, a double mastectomy, body image struggles and the challenges of survivorship.
Learn why hepatitis B can reactivate during cancer treatment, which therapies increase the risk and how antiviral medicines can help protect liver health.
After her sister’s Hodgkin lymphoma diagnosis, remission and relapse, a caregiver reflects on follow-up care, guilt and finding hope between cancer battles.
After a pancreatic cancer diagnosis upended his life and career, one survivor reflects on treatment, resilience and finding hope more than a decade later.
The American Society of Hematology published 2026 guidelines for adults with myelofibrosis on Oct. 14, 2026, with 10 recommendations on genetic testing, JAK inhibitors, anemia, transplant referral and aspirin.
Advertisement
Advertisement
Trending on CURE
1
Why Cancer Screening Remains Important for Long-Term Cancer Survivors
2
FDA Grants Traditional Approval to Keytruda for TMB-H Solid Tumors
3
Breast Cancer at 30: Aisha Shares the Challenges of Motherhood, Body Image and Life After Treatment
4
FDA Clears AI Tool Using MRI to Gauge Breast Cancer Recurrence
5